Organization Overview
Alternative names
abiraterone (zytiga) (1 trial)
acetylsalicylic acid (aspirin) (1 trial)
atezolizumab (Tecentriq) (7 trials)
atorvastatin (lipitor) (1 trial)
autologous hematopoietic stem cells (3 trials)
bacille calmette-guerin (1 trial)
bevacizumab (avastin) (10 trials)
bicalutamide (casodex) (3 trials)
bleomycin (blenoxane) (2 trials)
buserelin (receptal) (1 trial)
cabazitaxel (jevtana kit) (3 trials)
carboplatin (paraplatin) (17 trials)
celecoxib (celebrex) (1 trial)
cetuximab (erbitux) (9 trials)
chlorambucil (Leukeran) (1 trial)
cytarabine (cytosar-u) (4 trials)
dacarbazine (dtic-dome) (3 trials)
dactinomycin (cosmegen) (3 trials)
darolutamide (Nubeqa) (4 trials)
dexmedetomidine (precedex) (1 trial)
dinutuximab (unituxin) (2 trials)
docetaxel (taxotere) (14 trials)
doxorubicin (Doxil) (19 trials)
epirubicin (ellence) (4 trials)
escitalopram (lexapro) (2 trials)
estramustine (emcyt) (1 trial)
etoposide (vepesid) (23 trials)
everolimus (zortress) (6 trials)
Filgrastim (neupogen) (1 trial)
hydroxyurea (hydrea) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
irinotecan (Camptosar) (9 trials)
leuprolide (lupron) (2 trials)
lidocaine (xylocaine) (1 trial)
melphalan (alkeran) (5 trials)
nilutamide (nilandron) (1 trial)
nivolumab (opdivo) (16 trials)
oxaliplatin (eloxatin) (12 trials)
pazopanib (votrient) (2 trials)
prednisone (meticorten) (4 trials)
procarbazine (matulane) (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)
rituximab (rituxan) (6 trials)
sacituzumab govitecan (Trodelvy) (1 trial)
sargramostim (leukine) (4 trials)
tapentadol (nucynta) (1 trial)
thyrotropin (Thyropar) (4 trials)
trabectedin (yondelis) (4 trials)
trastuzumab (herceptin) (2 trials)
triptorelin (Trelstar) (1 trial)
vinblastine (velban) (8 trials)
vincristine (oncovin) (13 trials)
vindesine (Eldisine) (1 trial)
177lu-dota0-tyr3-octreotate (Dotatate) (1 trial)
abemaciclib (verzenio) (1 trial)
aldesleukin (Proleukin) (1 trial)
anastrozole (arimidex) (1 trial)
azithromycin (zithromax) (1 trial)
binimetinib (mektovi) (2 trials)
Bismuth Subcitrate Potassium (Pylera) (1 trial)
bortezomib (velcade) (3 trials)
capecitabine (xeloda) (4 trials)
catumaxomab (Removab) (1 trial)
clarithromycin (biaxin) (1 trial)
crizotinib (xalkori) (2 trials)
dabrafenib (tafinlar) (1 trial)
decitabine (dacogen) (1 trial)
dostarlimab (Jemperli) (1 trial)
enzalutamide (xtandi) (1 trial)
erlotinib (tarceva) (2 trials)
exemestane (aromasin) (2 trials)
fulvestrant (faslodex) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
idarubicin (idamycin) (1 trial)
indocyanine green (ic-green) (2 trials)
interferon alpha-2a (roferon-a) (1 trial)
iobenguane sulfate i-131 (1 trial)
ipilimumab (yervoy) (9 trials)
isotretinoin (Accutane) (1 trial)
lenvatinib (lenvima) (2 trials)
lorlatinib (lorbrena) (1 trial)
metronidazole (flagyl) (1 trial)
nilotinib (tasigna) (2 trials)
olaparib (lynparza) (5 trials)
omeprazole (prilosec) (1 trial)
palbociclib (ibrance) (3 trials)
panitumumab (vectibix) (1 trial)
pasireotide (signifor) (1 trial)
pertuzumab (perjeta) (1 trial)
pravastatin (pravachol) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
regorafenib (stivarga) (1 trial)
ribociclib (kisqali) (1 trial)
selumetinib (Koselugo) (4 trials)
sorafenib (nexavar) (2 trials)
sotorasib (LUMAKRAS) (1 trial)
tamoxifen (nolvadex) (1 trial)
tazemetostat (Tazverik) (1 trial)
temozolomide (temodar) (9 trials)
temsirolimus (torisel) (2 trials)
tetracycline (tetrex) (1 trial)
topotecan (hycamtin) (3 trials)
trametinib (mekinist) (1 trial)
tremelimumab (Imjudo) (5 trials)
trifluridine (viroptic) (1 trial)
tumor-pulsed dendritic cells (1 trial)
Adenocarcinoma (Phase 3)
Aggression (Phase 2)
Anus Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 4)
Burkitt Lymphoma (Phase 3)
Cancer Pain (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Carotid Body Tumor (Phase 2)
Central Nervous System Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 3)
Disease (Phase 2)
Disease Progression (Phase 2)
Endocrine Gland Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Fibrosis (Phase 2)
Gastrointestinal Stromal Tumors (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hematologic Neoplasms (Phase 2)
Hepatoblastoma (Phase 2)
Hodgkin Disease (Phase 3)
Hypersensitivity (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 3)
Laryngeal Neoplasms (Phase 3)
Leiomyosarcoma (Phase 3)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Medulloblastoma (Phase 2)
Melanoma (Phase 3)
Microsatellite Instability (Phase 2)
Mouth Neoplasms (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Connective and Soft Tissue (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Glandular and Epithelial (Phase 2)
Neoplasms, Second Primary (Phase 2)
Nervous System Neoplasms (Phase 2)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Oropharyngeal Neoplasms (Phase 3)
Osteosarcoma (Phase 3)
Ovarian Neoplasms (Phase 2)
Pain, Postoperative (Phase 4)
Pancreatic Neoplasms (Phase 2)
Paraganglioma (Phase 2)
Penile Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Pheochromocytoma (Phase 2)
Polycythemia (Phase 1)
Polycythemia Vera (Phase 1)
Precancerous Conditions (Phase 1)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 3)
Recurrence (Phase 3)
Rhabdomyosarcoma (Phase 3)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Seminoma (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 2)
Stress, Psychological (Phase 3)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 3)
Thrombocythemia, Essential (Phase 1)
Thrombocytosis (Phase 1)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Carcinoma, Anaplastic (Phase 1)
Thyroid Diseases (Phase 3)
Thyroid Neoplasms (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Ulcer (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 2)
Visceral Pain (Phase 3)
Wilms Tumor (Phase 3)
